REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Schonfeld Strategic Advisors LLC 84,000$2,126,0400.02%
Caption Management, LLC 40,200$1,017,4620.02%
VICTORY CAPITAL MANAGEMENT INC 564,355$14,283,8250.02%
TILIA FIDUCIARY PARTNERS, INC. 600$15,1860.01%
Qube Research & Technologies Ltd 138,597$3,507,8900.01%
JPMORGAN CHASE & CO 4,693,888$118,802,3050.01%
Invesco Ltd. 1,748,825$44,262,7620.01%
Cape Investment Advisory, Inc. 877$22,1970.01%
SEI INVESTMENTS CO 271,079$6,861,0590.01%
PRINCIPAL FINANCIAL GROUP INC 620,489$15,704,5640.01%
HighTower Advisors, LLC 195,050$4,936,0000.01%
DENALI ADVISORS LLC 1,100$27,8410.01%
Walleye Capital LLC 113,788$2,879,9740.01%
GOLDMAN SACHS GROUP INC 1,740,902$44,062,2300.01%
GTS SECURITIES LLC 11,024$279,0170.01%
China Universal Asset Management Co., Ltd. 1,102$280.01%
MetLife Investment Management, LLC 43,980$1,113,1340.01%
Renaissance Technologies 210,517$5,3280.01%
BNP PARIBAS FINANCIAL MARKETS 221,809$5,613,9860.01%
STATE OF WISCONSIN INVESTMENT BOARD 93,178$2,358,3350.01%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.